References
- Engelman R. M., Rousow J. H., Dobbs W. A. Fluosol DA, artificial blood for total cardiopulmonary bypass. Ann Thorac Surg 1981; 32: 528–535
- Harjula A., Mattila S., Järvinen A., Salmenperä M., Merikallio E. Endothelial cell damage following crystalloid cardioplegic infusion. Scanning electron microscope study of coronary bypass grafts. Arch Surg 1984; 119: 946–949
- Harjula A., Mattila S., Mattila I., Härkönen M., Myllärniemi H., Nickels J., Merikallio E. Coronary endothelial damage after crystalloid cardioplegia. J Cardiovasc Surg 1984; 25: 147–152
- Harjula A., Mattila S., Myllärniemi H., Mattila I., Mattila P., Salmenperä M., Merikallio E. Effects of synthetic blood and crystalloid cardioplegic solutions on coronary endothelium. An experimental scanning electron microscope study. Surg Res 1984, (in press)
- Harjula A., Mattila S., Salmenperä M., Härkönen M., Kyösola K., Mattila I., Mattila P., Aalto-Setälä K., Rechardt L., Merikallio E. Synthetic blood as myocardial preservative. Manuscript submitted to. Surg Res. 1984
- Hearse D. J., Stewart D. A., Braimbridge M. V. Myocardial protection during ischemic cardiac arrest. J Thorac Cardiovasc Surg 1978; 75: 877–885
- Hicks G. L., Arnold W., DeWall R. A. Fluorocarbon cardioplegia and myocardial protection. Ann Thorac Surg 1983; 35: 500–503
- Kanter K. R., Jaffin J. H., Ehrlichmann R. J., Flaherty J. T., Gott V. L., Gardner T. J. Superiority of perfluorocarbon over blood and crystalloid cardioplegia. Circulation 1980; 62(III)323
- Kraft L. F., Katholi R. E., Woods W. T., James T. N. Attenuation by magnesium of the electro-physiologic effects of hyperkalemia on human and canine heart cells. Am J Cardiol 1980; 45: 1189–1195
- Long D. Fluorocarbons and synthetic bloods: Capabilities and future uses. Pathophysiology and techniques of cardiopulmonary bypass. Cardiothoracic Surgery series, Vol. 1. Williams & Wilkins, Baltimore 1982, 1982
- Mitsuno T., Ohyanagi H., Naito R. Clinical studies of a perfluorochemical whole blood substitute (Fluosol DA). Summary of 186 cases. Ann Surg 1982; 195: 60–69
- Naito R., Yokoyama K. Perfluorochemical blood substitutes Fluosol-43, Fluosol DA 20% and 35%. The Green Cross Corp., Osaka, Japan. Technical Information Series 1978; 1978: No. 5
- Tyers G. F. Cardioplegic additives. A critical review. A textbook of clinical cardioplegia, R. M. Engelman, S. Levitsky. Futura Publishing Company, Mount Kisco, New York 1982; 139–155, 1982
- Wesseler E. P., Iltis R., Clark L. C., Jr. The solubility of oxygen in highly fluorinated liquids. J Fluorine Chem 1977; 9: 137